ABOUT TUBERCULOSIS TREATMENT USING SAFFRON

Pretomanid is currently being examined as Section of a combination regimen like moxifloxacin and PZA for the treatment of both drug-vulnerable and drug-resistant tuberculosis (ClinicalTrials.gov identifier: NCT02193776). Bedaquiline, approved because of the US FDA for treatment of multidrug-resistant tuberculosis in 2012, is likewise becoming inves